These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Toronto Psoriatic Arthritis Screening (ToPAS) questionnaire: a report from the GRAPPA 2009 annual meeting. Chandran V; Gladman DD J Rheumatol; 2011 Mar; 38(3):546-7. PubMed ID: 21362783 [TBL] [Abstract][Full Text] [Related]
3. Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Mease PJ; Boehncke WH; Gladman DD J Rheumatol; 2013 Aug; 40(8):1407-9. PubMed ID: 23908533 [TBL] [Abstract][Full Text] [Related]
4. Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire and the role of dermatologists: a report from the GRAPPA 2009 annual meeting. Dominguez P; Husni ME; Garg A; Qureshi AA J Rheumatol; 2011 Mar; 38(3):548-50. PubMed ID: 21362784 [TBL] [Abstract][Full Text] [Related]
5. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting. Armstrong AW; Callis Duffin K; Garg A; Gelfand JM; Gottlieb AB; Krueger GG; Qureshi AA; Rosen CF J Rheumatol; 2012 Nov; 39(11):2204-10. PubMed ID: 23118289 [TBL] [Abstract][Full Text] [Related]
6. Psoriasis and psoriatic arthritis video project: an update from the 2012 GRAPPA annual meeting. Callis Duffin K; Armstrong AW; Mease PJ J Rheumatol; 2013 Aug; 40(8):1455-6. PubMed ID: 23908546 [TBL] [Abstract][Full Text] [Related]
7. Psoriasis Epidemiology Screening Tool (PEST): a report from the GRAPPA 2009 annual meeting. Helliwell PS J Rheumatol; 2011 Mar; 38(3):551-2. PubMed ID: 21362785 [TBL] [Abstract][Full Text] [Related]
8. Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics. Mease PJ; Gladman DD; Helliwell P; Khraishi MM; Fuiman J; Bananis E; Alvarez D J Am Acad Dermatol; 2014 Oct; 71(4):649-55. PubMed ID: 24974240 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Haroon M; Kirby B; FitzGerald O Ann Rheum Dis; 2013 May; 72(5):736-40. PubMed ID: 22730367 [TBL] [Abstract][Full Text] [Related]
10. Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Callis Duffin K; Gladman DD; Gottlieb AB; Goel N J Rheumatol Suppl; 2019 Jun; 95():1-3. PubMed ID: 31154397 [TBL] [Abstract][Full Text] [Related]
11. Prologue: 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Mease PJ; Gladman DD J Rheumatol; 2011 Mar; 38(3):522-5. PubMed ID: 21362779 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the Persian versions of two psoriatic arthritis screening questionnaires early arthritis for psoriatic patients questionnaire (EARP) and psoriasis epidemiology screening tool (PEST) in Iranian psoriatic patients. Lajevardi V; Ghodsi SZ; Shafiei M; Teimourpour A; Etesami I Turk J Med Sci; 2021 Feb; 51(1):159-166. PubMed ID: 32927935 [TBL] [Abstract][Full Text] [Related]
13. Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting. Duffin KC; Garg A; Armstrong AW; Helliwell P; Mease PJ J Rheumatol; 2014 Jun; 41(6):1240-3. PubMed ID: 24882862 [TBL] [Abstract][Full Text] [Related]
14. Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Boehncke WH; Gladman DD J Rheumatol; 2014 Jun; 41(6):1194-6. PubMed ID: 24882850 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Ibrahim GH; Buch MH; Lawson C; Waxman R; Helliwell PS Clin Exp Rheumatol; 2009; 27(3):469-74. PubMed ID: 19604440 [TBL] [Abstract][Full Text] [Related]
16. Assessment of four screening tools and retrieval of key questions to detect undiagnosed psoriatic arthritis in Chinese patients with psoriasis: A multicenter study. Cui R; Chen M; Li X; Wang Q; Tong Q; Zhang H; Chen Z; Tao YL; Bi XL; Deng H; Yuan DF; He DY; Ding YF; Dai SM J Dermatol; 2022 Jun; 49(6):615-623. PubMed ID: 35318711 [TBL] [Abstract][Full Text] [Related]
17. Development of screening tools to identify psoriatic arthritis. Dominguez P; Gladman DD; Helliwell P; Mease PJ; Husni ME; Qureshi AA Curr Rheumatol Rep; 2010 Aug; 12(4):295-9. PubMed ID: 20617467 [TBL] [Abstract][Full Text] [Related]
18. Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Helliwell PS; Gladman DD; Gottlieb AB J Rheumatol Suppl; 2018 Jun; 94():1-3. PubMed ID: 29858345 [TBL] [Abstract][Full Text] [Related]
19. Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 Annual Meeting. Gottlieb AB; Armstrong AW; FitzGerald O; Gladman DD J Rheumatol; 2023 Nov; 50(Suppl 2):1-3. PubMed ID: 37419627 [TBL] [Abstract][Full Text] [Related]
20. GRAPPA Trainees Symposium 2018: A Report from the GRAPPA 2018 Annual Meeting. Ford AR; Mascia E; Boehncke WH; Ritchlin CT J Rheumatol Suppl; 2019 Jun; 95():4-10. PubMed ID: 31154398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]